Are Quinolone-Resistant Uropathogenic Escherichia coli Less Virulent? J Vila, K Simon, J Ruiz, JP Horcajada, M Velasco, M Barranco, A Moreno, ... The Journal of infectious diseases 186 (7), 1039-1042, 2002 | 220 | 2002 |
Differences in Virulence Factors among Clinical Isolates of Escherichia coli Causing Cystitis and Pyelonephritis in Women and Prostatitis in Men J Ruiz, K Simon, JP Horcajada, M Velasco, M Barranco, G Roig, ... Journal of clinical microbiology 40 (12), 4445-4449, 2002 | 216 | 2002 |
Emergence of imipenem resistance in clinical Escherichia coli during therapy J Oteo, A Delgado-Iribarren, D Vega, V Bautista, MC Rodríguez, ... International journal of antimicrobial agents 32 (6), 534-537, 2008 | 181 | 2008 |
Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? M Velasco, JA Martínez, A Moreno-Martínez, JP Horcajada, J Ruiz, ... Clinical infectious diseases 37 (8), 1127-1130, 2003 | 164 | 2003 |
Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis M Velasco, V Castilla, J Sanz, G Gaspar, E Condes, C Barros, M Cervero, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (2), 148-152, 2009 | 162 | 2009 |
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis JM Miró, JM Entenza, A Del Río, M Velasco, X Castañeda, ... Antimicrobial agents and chemotherapy 56 (8), 4511-4515, 2012 | 157 | 2012 |
Mortality among adult patients admitted to the hospital on weekends R Barba, JE Losa, M Velasco, C Guijarro, GG de Casasola, A Zapatero European Journal of Internal Medicine 17 (5), 322-324, 2006 | 153 | 2006 |
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study G Peralta, M Lamelo, P Álvarez-García, M Velasco, A Delgado, ... BMC infectious diseases 12, 1-7, 2012 | 135 | 2012 |
Search for third-generation scalar leptoquarks in the t-tau channel in proton-proton collisions at sqrt (s)= 8 TeV CMS collaboration arXiv preprint arXiv:1503.09049, 2015 | 108* | 2015 |
Decreased Invasive Capacity of Quinolone-Resistant Escherichia coli in Patients with Urinary Tract Infections M Velasco, JP Horcajada, J Mensa, AM Martinez, J Vila, JA Martinez, ... Clinical infectious diseases 33 (10), 1682-1686, 2001 | 107 | 2001 |
The first case of Ebola virus disease acquired outside Africa JM Parra, OJ Salmerón, M Velasco New England Journal of Medicine 371 (25), 2439-2440, 2014 | 102 | 2014 |
Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections A Soriano, J Gomez, L Gomez, JR Azanza, R Pérez, F Romero, M Pons, ... European Journal of Clinical Microbiology & Infectious Diseases 26, 353-356, 2007 | 98 | 2007 |
Search for an exotic decay of the Higgs boson to a pair of light pseudoscalars in the final state of two muons and two leptons in proton-proton collisions at 13 … CMS collaboration arXiv preprint arXiv:1805.04865, 2018 | 81 | 2018 |
Distintos instrumentos para un mismo fin. Los instrumentos de las políticas públicas como herramienta para el análisis M Velasco VIII Congreso Español de Ciencia Política y de la Administración, 18-20, 2007 | 69 | 2007 |
Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient M Velasco, A Morán, MJ Téllez New England Journal of Medicine 340 (22), 1765-1766, 1999 | 67 | 1999 |
Elevated liver enzymes following initiation of antiretroviral therapy M Velasco, C Guijarro Jama 283 (19), 2526-2527, 2000 | 62 | 2000 |
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: prevalence and patient characteristics J Berenguer, A Rivero, I Jarrín, MJ Núñez, MJ Vivancos, M Crespo, ... Open forum infectious diseases 3 (2), ofw059, 2016 | 60 | 2016 |
The human microbiome in sickness and in health T Requena, M Velasco Revista Clínica Española (English Edition) 221 (4), 233-240, 2021 | 56 | 2021 |
Fulminant herpes hepatitis in a healthy adult: a treatable disorder? M Velasco, E Llamas, M Guijarro-Rojas, M Ruiz-Yagüe Journal of clinical gastroenterology 28 (4), 386-389, 1999 | 54 | 1999 |
Evaluation of Inflammatory and Renal-Injury Markers in Women Treated with Antibiotics for Acute Pyelonephritis Caused by Escherichia coli JP Horcajada, M Velasco, X Filella, L Alvarez, E De Lazzari, JL Marín, ... Clinical and Vaccine Immunology 11 (1), 142-146, 2004 | 43 | 2004 |